Sylvia P.
- Country
- Germany
- Department
- KLIFOS - Klinische Forschung Osnabrueck
Research Overview
- Efficacy and Safety of Lebrikizumab in Adults With Nummular Dermatitis Inadequately Controlled by Topical Corticosteroids: A Phase 3, Randomized, Placebo-Controlled Study
- Efficacy and Safety of LAD603 in Adults with Severe to Very Severe Alopecia Areata: A Phase 2, Randomized, Placebo-Controlled Study
- Efficacy of a polymerized mannan‑conjugated Phleum pratense and Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis/rhinoconjunctivitis
Data & Insights
Has run more than one trial at 305 of 624 partner sites.
Specializations
Dermatological Conditions
The investigator specializes in treating various chronic skin disorders, with particular focus on moderate to severe plaque psoriasis and atopic dermatitis.
- Plaque Psoriasis Management
- Atopic Hand Eczema
- Pediatric Atopic Dermatitis
Research interests include novel therapeutic approaches for inflammatory skin conditions.
Allergic Disorders
Expertise in treating allergic respiratory conditions and chronic spontaneous urticaria, including innovative immunotherapy approaches.
- House Dust Mite Allergies
- Seasonal Allergic Rhinitis
- Rhinoconjunctivitis
Focuses on both adult and pediatric allergic conditions using targeted therapeutic interventions.
Therapeutic Innovations
Active involvement in evaluating novel biological therapies and immunomodulatory treatments for dermatological and allergic conditions.
- Monoclonal Antibody Therapies
- Long-term Safety Studies
- Subcutaneous Immunotherapy
Specializes in investigating treatment durability and therapeutic responses in chronic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.